Bluebird bio Inc (BLUE) — Capital Reinvestment Ratio
Latest as of June 2020:
0.12x
Bluebird bio Inc (BLUE) has a Capital Reinvestment Ratio of 0.12x as of June 2020, meaning it reinvests 0% of its operating cash flow ($39.74 Million) in capital expenditures ($4.80 Million). See Bluebird bio Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.12x
Capex / Operating Cash Flow
Operating Cash Flow
$39.74 Million
USD
Capital Expenditures
$4.80 Million
USD
Data as of
Jun 2020
Most recent filing
Bluebird bio Inc Capital Reinvestment Ratio (2013–2013)
This chart tracks Bluebird bio Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Bluebird bio Inc (2013–2013)
Year-by-year Capital Reinvestment Ratio for Bluebird bio Inc from 2013 to 2013. For live market cap and broader valuation context, see BLUE stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2013 | 0.20x | $43.45 Million | $8.67 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow